Research > ETFs > ETF / ETP Commentary > 

Small-Cap Pullback May Make This ETF Appealing

With soaring Treasury yields the likely culprit, previously hot small-cap stocks and ETFs are retreating. For example, the widely followed Russell 2000 Index shed 6.43% over the three months ending September 30.To its credit, the ALPS O’Shares U.S. Small-Cap Quality Dividend ETF (OUSM A) was significantly less bad than the small-cap benchmark. It slipped just 1.29% over the course of the third quarter. Granted, three months is a short timeline, particularly when discussing the merits of dividend and small-cap investing. But OUSM’s less bad third-quarter showing is a testament to the ETF’s quality focus. Said another way, by some estimates, approximately 40% of Russell 2000 components aren’t profitable companies. And those are the very firms that are vulnerable to rising interest rates. So while this isn’t the “perfect” environment for smaller stocks, OUSM provides a compelling buffer against the Federal Reserve tightening rates. And that’s likely to happen once more before the end of 2026.More Reasons to Consider OUSMWhile there macroeconomic challenges, including high gas prices and other forms of sticky inflation, some experts believe the U.S. economy is mostly solid. That could portend long-term upside for smaller stocks and ETFs such as OUSM. “We do not believe that US small caps have permanently shifted to being an asset class dominated by speculative growth opportunities, and we expect the reversion to more fundamentally driven factors – such as a focus on companies’ financial strength and operations – to continue,” noted BNP Paribas. The $773.33 million OUSM, which turns 10 years old in December, has another perk. That is its robust exposure to cyclical sectors, including industrials, which account for more than 20% of the ETF’s roster.OUSM: Valid Consideration“If the cyclical recovery remains durable, market segments with higher exposure to the so-called ‘real’ economy should disproportionately benefit. Smaller, domestically focused companies are likely to be the prime beneficiaries of US-centric trends such as reshoring and increased infrastructure spending,” added BNP Paribas. Additionally, ETF’s such as OUSM remain valid considerations for investors heavily exposed to large- and mega-cap growth stocks. “The structural composition of small-cap indices offers a level of sector diversification and cyclicality lacking in larger indices. Small caps tend to be less concentrated in terms of sector exposure or top holdings meaning returns are not dominated by a small group of very large companies,” concluded the French bank. For more news, information, and analysis, visit the ETF Building Blocks Content Hub. VettaFi LLC (“VettaFi”) is the index provider for OUSM, for which it receives an index licensing fee. However, OUSM is not issued, sponsored, endorsed, or sold by VettaFi, and VettaFi has no obligation or liability in connection with the issuance, administration, marketing, or trading of OUSM.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.